ReviewDrug safety2017
Targeting Interleukin-5 or Interleukin-5Rα: Safety Considerations.
Diego Bagnasco et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ReviewDrug safety2017
Diego Bagnasco et al.PubMed ↗Publisher ↗
No numbers read from the abstract.